title: Alzheimer's disease is characterized by more low-density erythrocytes with increased volume and enhanced β-amyloid x-40 content.
authors.forename: P
authors.initials: P
authors.lastname: Järemo
authors.forename: M
authors.initials: M
authors.lastname: Milovanovic
authors.forename: S
authors.initials: S
authors.lastname: Nilsson
authors.forename: C
authors.initials: C
authors.lastname: Buller
authors.forename: C
authors.initials: C
authors.lastname: Post
authors.forename: B
authors.initials: B
authors.lastname: Winblad
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016022:Case-Control Studies; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40)